» View Pricing
Printed from the IBC Life Sciences Web site on May 22, 2013 5:29 PM ET.
Page location: http://www.ibclifesciences.com/antibodyeng/overview.xml
December 08-12, 2013 · Hyatt Regency Huntington Beach Resort & Spa · Huntington Beach, CA
Join IBC Life Sciences' LinkedIn group: Antibody & Protein Therapeutics - From Discovery to Production
Join our priority contact list and receive the latest event news.
See what our 2012 attendees had to say about their experience
» Read testimonials
Huntington Beach, CA is conveniently located to 3 airports: Los Angeles (LAX), Orange County (SNA) and Long Beach (LGB)
View a full list of the scientific poster presentations that were on display at Antibody Engineering and Antibody Therapeutics 2012.
Download the 2012 onsite event guide to see the caliber of presentations
Announcing IBC's Antibody Engineering & Therapeutics, just for 2013, is moving to a refreshing new beachfront location in Huntington Beach, CA. This gorgeous venue is easily accessible by Los Angeles (LAX), Orange County (SNA) and Long Beach (LGB) airports! Join us December 8-12, 2013 at the world's leading forum for the exchange of cutting-edge protein engineering science and antibody therapeutics now in development.
» We are now accepting speaker proposals for 2013 - submit your topic idea today!
Leroy Hood, M.D., Ph.D.
Institute for Systems Biology
Douglas A. Lauffenburger, Ph.D.
Ford Professor of Biological Engineering, Chemical Engineering, and Biology; Head, Department of Biological Engineering, Massachusetts Institute of Technology
Now in its 24th year, Antibody Engineering & Therapeutics has earned its reputation by consistently offering the most current academic research findings and most recent industry updates. Our attendees come back year after year for the information they need to stay abreast of the latest scientific trends in the antibody field. World-renowned scientists from across the globe convene at this event to share best practices and new approaches to exploit antibodies for developing novel medicines and vaccines. Learn about both the basic science of antibody engineering and the latest preclinical/clinical data, including safety and efficacy studies of the most cutting-edge antibody therapeutics now in development. We hope to see you this December in Huntington Beach!
Get the "inside look" of the 2012 meeting with this post conference report written by attendees and featured in mAbs Journal.
Authors: Peter-Christian Klöhn, Ulrich Wuellner, Nora Zizlsperger, Yu Zhou,Daniel Tavares, Sven Berger, Kirstin A. Zettlitz, Gabriele Proetzel, May Yong, Richard H.J. Begent, and Janice M. Reichert
» View the Report (PDF)
Here is a Sneak Peek at Some of the Exciting New Topics to be Covered: